CryoLife Inc. Hits New 52-Week High at $11.33 (CRY)
CryoLife (NYSE:CRY) set a new 52-week high on Thursday, Analyst Ratings Net reports. The company traded as high as $11.33 and last traded at $11.24, with a volume of 67,772 shares. The stock had previously closed at $11.07.
Separately, analysts at Zacks upgraded shares of CryoLife from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, October 30th. They now have a $9.40 price target on the stock.
CryoLife has a 52-week low of $5.52 and a 52-week high of $11.32. The stock’s 50-day moving average is $10.72 and its 200-day moving average is $8.28. The company has a market cap of $310.3 million and a P/E ratio of 33.75.
CryoLife (NYSE:CRY) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.07. The company had revenue of $36.30 million for the quarter, compared to the consensus estimate of $35.51 million. During the same quarter in the previous year, the company posted $0.08 earnings per share. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. Analysts expect that CryoLife will post $0.60 EPS for the current fiscal year.
CryoLife, Inc (NYSE:CRY) is a biological medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.